Clinical Trial Update: ACT-MBC: A Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer (MBC)

View source ↗

Summary

ACT-MBC is a study of circulating tumor cells in metastatic breast cancer sponsored by Menarini Silicon Biosystems. The trial status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Menarini Silicon Biosystems, INC | Conditions: Metastatic Breast Cancer | Status: ACTIVE_NOT_RECRUITING